We are steadily advancing internationalization which is a long-term development strategy for Chiheal Biomed. The company consistently emphasizes efficient and breakthrough R&D innovation, maintaining a balance between independent R&D and open collaboration. By integrating global resources and strengthening international cooperation on the foundation of endogenous development, Chiheal Biomed is committed to achieving sustainable growth in the global pharmaceutical landscape.

Chiheal Biomed has always upheld innovation, persistently focusing on R&D from the technological forefront. Through relentless exploration and research, the company has strategically positioned itself globally with patents in the fields of innovative drug development, long-acting peptide drug development, and generic drug development. Chiheal Biomed is accelerating its expansion into the global market, targeting emerging markets, and actively seeking external collaborations with independent intellectual property rights. These efforts are aimed at propelling Chinese innovation in pharmaceuticals onto the international stage.

Chiheal Biomed actively implements the 'Belt and Road' strategy to enhance the global accessibility of medications for patients in different regions. We actively participate in the construction of global public health initiatives, providing affordable innovative drug solutions to patients worldwide. Through continuous development of new technologies and the provision of high-quality products and professional services, we are committed to offering outstanding products and quality services in the pharmaceutical industry. Our dedication to genuine technological innovation serves the public and contributes to the cause of human health.